|
1
|
Rink C and Khanna S: MicroRNA in ischemic
stroke etiology and pathology. Physiol Genomics. 43:521–528. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Laterza OF, Lim L, Garrett-Engele PW, et
al: Plasma MicroRNAs as sensitive and specific biomarkers of tissue
injury. Clin Chem. 55:1977–1983. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weng H, Shen C, Hirokawa G, et al: Plasma
miR-124 as a biomarker for cerebral infarction. Biomed Res.
32:135–141. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zeng L, Liu J, Wang Y, et al: MicroRNA-210
as a novel blood biomarker in acute cerebral ischemia. Front Biosci
(Elite Ed). 3:1265–1272. 2011.PubMed/NCBI
|
|
5
|
Tan KS, Armugam A, Sepramaniam S, et al:
Expression profile of MicroRNAs in young stroke patients. PLoS One.
4:e76892009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jeyaseelan K, Lim KY and Armugam A:
MicroRNA expression in the blood and brain of rats subjected to
transient focal ischemia by middle cerebral artery occlusion.
Stroke. 39:959–966. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Buller B, Liu X, Wang X, et al:
MicroRNA-21 protects neurons from ischemic death. FEBS J.
277:4299–4307. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qian L, Van Laake LW, Huang Y, Liu S,
Wendland MF and Srivastava D: miR-24 inhibits apoptosis and
represses Bim in mouse cardiomyocytes. J Exp Med. 208:549–560.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Siegel C, Li J, Liu F, Benashski SE and
McCullough LD: miR-23a regulation of X-linked inhibitor of
apoptosis (XIAP) contributes to sex differences in the response to
cerebral ischemia. Proc Natl Acad Sci USA. 108:11662–11667. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yin KJ, Deng Z, Huang H, et al: miR-497
regulates neuronal death in mouse brain after transient focal
cerebral ischemia. Neurobiol Dis. 38:17–26. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi L, Chen J, Yang J, Pan T, Zhang S and
Wang Z: MiR-21 protected human glioblastoma U87MG cells from
chemotherapeutic drug temozolomide induced apoptosis by decreasing
Bax/Bcl-2 ratio and caspase-3 activity. Brain Res. 1352:255–264.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dong J, Zhao YP, Zhou L, Zhang TP and Chen
G: Bcl-2 upregulation induced by miR-21 via a direct interaction is
associated with apoptosis and chemoresistance in MIA PaCa-2
pancreatic cancer cells. Arch Med Res. 42:8–14. 2011. View Article : Google Scholar
|
|
13
|
McDonald JS, Milosevic D, Reddi HV, Greb
SK and Algeciras-Schimnich A: Analysis of circulating microRNA:
preanalytical and analytical challenges. Clin Chem. 57:833–840.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Devaux Y, Vausort M, Goretti E, et al: Use
of circulating microRNAs to diagnose acute myocardial infarction.
Clin Chem. 58:559–567. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen C, Ridzon DA, Broomer AJ, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen X, Ba Y, Ma L, et al:
Characterization of microRNAs in serum: a novel class of biomarkers
for diagnosis of cancer and other diseases. Cell Res. 18:997–1006.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yao R, Ma Y, Du Y, et al: The altered
expression of inflammation-related microRNAs with microRNA-155
expression correlates with Th17 differentiation in patients with
acute coronary syndrome. Cell Mol Immunol. 8:486–495. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kroh EM, Parkin RK, Mitchell PS and Tewari
M: Analysis of circulating microRNA biomarkers in plasma and serum
using quantitative reverse transcription-PCR (qRT-PCR). Methods.
50:298–301. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fichtlscherer S, Zeiher AM and Dimmeler S:
Circulating microRNAs: biomarkers or mediators of cardiovascular
diseases? Arterioscler Thromb Vasc Biol. 31:2383–2390. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lorenzen JM and Thum T: Circulating and
urinary microRNAs in kidney disease. Clin J Am Soc Nephrol.
7:1528–1533. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schwarzenbach H, Hoon DS and Pantel K:
Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev
Cancer. 11:426–437. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Doyle KP, Simon RP and Stenzel-Poore MP:
Mechanisms of ischemic brain damage. Neuropharmacology. 55:310–318.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xie Y, Tobin LA, Camps J, et al:
MicroRNA-24 regulates XIAP to reduce the apoptosis threshold in
cancer cells. Oncogene. 32:2442–2451. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Frankel LB, Christoffersen NR, Jacobsen A,
Lindow M, Krogh A and Lund AH: Programmed cell death 4 (PDCD4) is
an important functional target of the microRNA miR-21 in breast
cancer cells. J Biol Chem. 283:1026–1033. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Papagiannakopoulos T, Shapiro A and Kosik
KS: MicroRNA-21 targets a network of key tumor-suppressive pathways
in glioblastoma cells. Cancer Res. 68:8164–8172. 2008. View Article : Google Scholar : PubMed/NCBI
|
